Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

AdventHealth Orlando-Site Number:8400001

Orlando, Florida, United States, 32804

Massachusetts General Hospital-Site Number:8400002

Boston, Massachusetts, United States, 02114

University of Wisconsin-Site Number:8400004

Madison, Wisconsin, United States, 53792

Investigational Site Number :0320003

Capital Federal, Buenos Aires, Argentina, 1012

Investigational Site Number :0320001

Pergamino, Buenos Aires, Argentina, B2700CPM

Investigational Site Number :0320002

Rosario, Santa Fe, Argentina, 2000

Investigational Site Number :1520002

Temuco, La Araucanía, Chile, 4810561

Investigational Site Number :1520003

Santiago, Reg Metropolitana De Santiago, Chile, 7500921

Investigational Site Number :1520001

Santiago, Reg Metropolitana De Santiago, Chile, 8420383

Investigational Site Number :3480003

Budapest, Hungary, 1122

Investigational Site Number :3480002

Debrecen, Hungary, 4032

Investigational Site Number :4100003

Goyang-si, Gyeonggi-do, Korea, Republic of, 10408

Investigational Site Number :4100001

Seoul, Seoul-teukbyeolsi, Korea, Republic of, 03080

Investigational Site Number :4100002

Seoul, Seoul-teukbyeolsi, Korea, Republic of, 06351

Investigational Site Number :5280002

Amsterdam, Netherlands, 1066 CX

Investigational Site Number :5280001

Rotterdam, Netherlands, 3015 GD

Investigational Site Number :5280003

Utrecht, Netherlands, 3584 CX

Investigational Site Number :6430001

Moscow, Russian Federation, 115478

Investigational Site Number :6430004

Pushkin, Saint- Petersburg, Russian Federation, 196603

Investigational Site Number :6430002

Saint -Petersburg, Russian Federation, 197758

Investigational Site Number :6430005

Saint-Petersburg, Russian Federation, 197110

Investigational Site Number :7240001

Barcelona, Barcelona [Barcelona], Spain, 08035

Investigational Site Number :7240003

Madrid, Madrid, Comunidad De, Spain, 28046

Investigational Site Number :7240002

Majadahonda, Madrid, Spain, 28222

Investigational Site Number :1580001

Taichung, Taiwan, 40447

Investigational Site Number :1580002

Tainan, Taiwan, 704

Investigational Site Number :1580003

Taipei, Taiwan, 11217

Investigational Site Number :7920003

Adana, Turkey, 01250

Investigational Site Number :7920004

Ankara, Turkey, 06100

Investigational Site Number :7920001

Istanbul, Turkey, 34722

Investigational Site Number :7920002

Izmir, Turkey

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 16, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments